Peggy Wallace

Insider Reports History

Entity
Individual
Location
C/O Cognition Therapeutics, Inc., 2500 Westchester Ave., Purchase, NY
Signature
/s/ John Brendan Doyle, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Peggy Wallace:

Stock Role Class Num Shares Value Price $ Report Date Ownership
COGNITION THERAPEUTICS INC Director Common Stock 52.5K $102K $1.95 Jun 7, 2024 Direct
COGNITION THERAPEUTICS INC Director Stock Option (right to buy) 8.5K Jun 7, 2024 Direct

Insider Reports Filed by Peggy Wallace

Symbol Company Period Transactions Value $ Form Type Date Filed Role
CGTX COGNITION THERAPEUTICS INC Jun 7, 2024 2 $0 4 Jun 11, 2024 Director
CGTX COGNITION THERAPEUTICS INC Jun 9, 2023 2 $0 4 Jun 13, 2023 Director
CGTX COGNITION THERAPEUTICS INC Nov 15, 2022 1 $15K 4 Nov 16, 2022 Director
CGTX COGNITION THERAPEUTICS INC Sep 27, 2022 1 $0 4 Sep 29, 2022 Director
CGTX COGNITION THERAPEUTICS INC Jun 10, 2022 1 $0 4/A Jun 23, 2022 Director
CGTX COGNITION THERAPEUTICS INC Oct 13, 2021 1 $36K 4 Oct 25, 2021 Director
CGTX COGNITION THERAPEUTICS INC Oct 7, 2021 0 $0 3 Oct 7, 2021 Director